[Immunisation schedule of the Spanish Association of Paediatrics: 2015 recommendations]

Insights

The Spanish Association of Paediatrics updates its optimal childhood immunization schedule annually, incorporating safety and effectiveness data for vaccines like hepatitis B, MMR, and DTaP.

Area of Science:

  • Pediatrics
  • Vaccinology
  • Public Health

Background:

  • The Advisory Committee on Vaccines (ACV) annually updates the recommended immunization schedule for children in Spain.
  • The schedule considers epidemiological data, vaccine safety, effectiveness, and efficiency.
  • The ACV aims to provide the optimal vaccination calendar for all children residing in Spain.

Purpose of the Study:

  • To present the updated annual immunization schedule recommended by the ACV for children in Spain.
  • To highlight key vaccine recommendations, including timing, dosage, and specific populations.
  • To advocate for the inclusion and accessibility of certain vaccines in the national schedule.

Main Methods:

  • Review of epidemiological data.
  • Evaluation of evidence on vaccine safety, effectiveness, and efficiency.
  • Expert consensus and recommendation development by the ACV.

Main Results:

  • Specific recommendations for hepatitis B (birth or 2 months), MMR and varicella (12 months, booster at 2-3 years), and DTaP/Tdap (6 years, booster at 11-12 years).
  • Emphasis on Tdap for pregnant women and newborns' contacts, and HPV vaccination for girls (11-12 years, 2-dose scheme).
  • Reiteration of pneumococcal vaccination recommendation, advocating for meningococcal B vaccine availability, and proposing free varicella vaccines.

Conclusions:

  • The updated schedule represents the optimal vaccination strategy for children in Spain.
  • Key vaccines like pneumococcal and meningococcal B should be integrated into routine immunization.
  • Increased accessibility and availability of vaccines such as varicella are crucial for public health.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...